ReviewInsights into imaging2018
An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines.
Review in Insights into imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies.Theranostics · 2021Pooled it
- Aggressive chronic prostatitis mimicking locally advanced prostate cancer with apparent extraprostatic extension: a case report.BMC urology · 2026Article
- The evolving PI-RADS paradigm.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Review
- RADS ALPHABET: news and tips for young and general radiologists.Insights into imaging · 2026Article
- Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer.BJUI compass · 2025Article
- A two-stage model for precise identification and Gleason grading of clinically significant prostate cancer: a hybrid approach.Journal of medical radiation sciences · 2025Article
- Interpreting Prostate Multiparametric MRI: Beyond Adenocarcinoma - Anatomical Variations, Mimickers, and Post-Intervention Changes.Seminars in ultrasound, CT, and MR · 2025Review
- Factors of interobserver variability in prostate tumor MRI delineation: impact of PI-QUAL score.La Radiologia medica · 2024Article
- A pictorial essay of PI-RADS pearls and pitfalls: toward less ambiguity and better practice.Abdominal radiology (New York) · 2024Review
- [Cancer imaging : the official publication of the International Cancer Imaging Society · 2024Article
- Expect the unexpected: investigating discordant prostate MRI and biopsy results.European radiology · 2024Article
- Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging.Physics and imaging in radiation oncology · 2024Article
- The Added Value of Prostate Magnetic Resonance Imaging to Patient Selection.The Permanente journal · 2024Article
- Patient-related characteristics predict prostate cancers in men with PI-RADS 4-5 to further optimize the diagnostic performance of MRI.Abdominal radiology (New York) · 2023Article
- A transfer learning nomogram for predicting prostate cancer and benign conditions on MRI.BMC medical imaging · 2023Article
- Addressing image misalignments in multi-parametric prostate MRI for enhanced computer-aided diagnosis of prostate cancer.Scientific reports · 2023Article
- Granulomatous prostatitis: mimicking locally advanced prostate adenocarcinoma.Acta bio-medica : Atenei Parmensis · 2023Article
- Article
- Prostate Cancer and Its Mimics-A Pictorial Review.Cancers · 2023Review
- Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial.Radiology · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe aim of the current report is to provide an update in the imaging interpretation of prostate cancer on multiparametric magnetic resonance imaging (mpMRI), with a special focus on how to discriminate pathological tissue from the most common pitfalls that may be encountered during daily clinical practice using the Prostate Imaging Reporting and Data System (PI-RADS) version 2 guidelines.
methodsAll the cases that are shown in this pictorial review comply with the European Society of Urogenital Radiology (ESUR) guidelines for technical mpMRI requirements.
resultsDespite the standardised manner to report mpMRI (PI-RADS v. 2), some para-physiologic appearances of the prostate can mimic cancer. As such, it is crucial to be aware of these pitfalls, in order to avoid the under/overestimation of prostate cancer.
conclusionsA detailed knowledge of normal and abnormal findings in mpMRI of the prostate is pivotal for an accurate management of the wide spectrum of clinical scenarios that radiologists may encounter during their daily practice. TEACHING POINTS: • Some para-physiologic appearances of the prostate may mimic cancer. • Knowledge of normal and abnormal findings in prostate mpMRI is pivotal. • Any radiologist involved in prostate mpMRI reporting should be aware of pitfalls.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.